Literature DB >> 21886174

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.

V Visconte, H Makishima, A Jankowska, H Szpurka, F Traina, A Jerez, C O'Keefe, H J Rogers, M A Sekeres, J P Maciejewski, R V Tiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21886174     DOI： 10.1038/leu.2011.232

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  103 in total

1.  Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

Authors:  Davide Rossi; Alessio Bruscaggin; Valeria Spina; Silvia Rasi; Hossein Khiabanian; Monica Messina; Marco Fangazio; Tiziana Vaisitti; Sara Monti; Sabina Chiaretti; Anna Guarini; Ilaria Del Giudice; Michaela Cerri; Stefania Cresta; Clara Deambrogi; Ernesto Gargiulo; Valter Gattei; Francesco Forconi; Francesco Bertoni; Silvia Deaglio; Raul Rabadan; Laura Pasqualucci; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 2.  Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?

Authors:  Leopold Sellner; Sascha Dietrich; Peter Dreger; Hanno Glimm; Thorsten Zenz
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

3.  Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.

Authors:  Sarah Abu Kar; Anna Jankowska; Hideki Makishima; Valeria Visconte; Andres Jerez; Yuka Sugimoto; Hideki Muramatsu; Fabiola Traina; Manuel Afable; Kathryn Guinta; Ramon V Tiu; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Seiji Kojima; Mikkael A Sekeres; Alan F List; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

4.  SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype.

Authors:  Valeria Visconte; Ali Tabarroki; Heesun J Rogers; Edy Hasrouni; Fabiola Traina; Hideki Makishima; Betty K Hamilton; Yang Liu; Christine O'Keefe; Alan Lichtin; Leonard Horwitz; Mikkael A Sekeres; Fred H Hsieh; Ramon V Tiu
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

5.  Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.

Authors:  Sabine Jeromin; Torsten Haferlach; Sandra Weissmann; Manja Meggendorfer; Christiane Eder; Niroshan Nadarajah; Tamara Alpermann; Alexander Kohlmann; Wolfgang Kern; Claudia Haferlach; Susanne Schnittger
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

6.  Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and de novo acute myeloid leukemia.

Authors:  Pedro Martin-Cabrera; Sabine Jeromin; Karolína Perglerovà; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

7.  Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.

Authors:  F Traina; V Visconte; P Elson; A Tabarroki; A M Jankowska; E Hasrouni; Y Sugimoto; H Szpurka; H Makishima; C L O'Keefe; M A Sekeres; A S Advani; M Kalaycio; E A Copelan; Y Saunthararajah; S T Olalla Saad; J P Maciejewski; R V Tiu
Journal:  Leukemia       Date:  2013-09-18       Impact factor: 11.528

8.  Jumping translocations in myelodysplastic syndromes.

Authors:  Cecilia C S Yeung; H Joachim Deeg; Colin Pritchard; David Wu; Min Fang
Journal:  Cancer Genet       Date:  2016-08-08

9.  Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

Authors:  Esther A Obeng; Ryan J Chappell; Michael Seiler; Michelle C Chen; Dean R Campagna; Paul J Schmidt; Rebekka K Schneider; Allegra M Lord; Lili Wang; Rutendo G Gambe; Marie E McConkey; Abdullah M Ali; Azra Raza; Lihua Yu; Silvia Buonamici; Peter G Smith; Ann Mullally; Catherine J Wu; Mark D Fleming; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

10.  Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.

Authors:  Véronique Gelsi-Boyer; Nathalie Cervera; François Bertucci; Mandy Brecqueville; Pascal Finetti; Anne Murati; Christine Arnoulet; Marie-Joelle Mozziconacci; Ken I Mills; Nicholas C P Cross; Norbert Vey; Daniel Birnbaum
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.